Clinical Trials Logo

Clinical Trial Summary

Acute limb ischemia (ALI) is a sudden decrease in limb perfusion due to either an embolic or a thrombotic vascular occlusion, defined as the presence of symptoms within two weeks of onset. The profound ischemia represents an emergency in which delayed treatment results in limb loss and, potentially, death. Therefore, timely diagnosis and proper treatments for ALI are important. Both surgical thrombectomy and endovascular treatment have benefits and drawbacks. Surgical thrombectomy using Fogarty embolectomy catheter has been the standard therapy because it is rapid and effective in cases of embolic ALI. However, blind surgical thrombectomy can result in poor revascularization or unexpected vascular injury in the presence of underlying arterial atherosclerosis or in the presence of subacute and chronic thrombi. In addition, thrombosis of runoff vessels is difficult to remove. Endovascular management using catheter-directed thrombolysis (CDT) has emerged as an alternative to surgery. It is less invasive, and does not directly damage the vascular endothelium with the capacity to clear thrombus in the small vessels. However, long treatment duration may worsen the clinical situation. Besides, a thrombus of more than two weeks does not respond well to the thrombolysis, and it is difficult to determine the exact stage of thrombus according to the clinical history. These problems may be minimized by combined treatment, which includes surgical thrombectomy and endovascular treatment.


Clinical Trial Description

The aim of our research is to evaluate the effectiveness and safety of combined treatment (surgical thrombectomy and endovascular treatment) for ALI with various clinical considerations ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04622878
Study type Interventional
Source Assiut University
Contact kerolos Raafat khalil Gad Basta, resident
Phone 00201223548723
Email kerolosbasta93@gmail.com
Status Not yet recruiting
Phase N/A
Start date December 1, 2020
Completion date December 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT05411315 - Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment N/A
Completed NCT04066387 - Characteristics and Prognosis of Patients With Critical Ischemia at High Risk of Amputation Managed by Endovascular Bypass: a Retrospective Study of 15 Patients
Completed NCT00453531 - Model System for Transient Forearm Blood Vessel Dysfunction Phase 1/Phase 2
Completed NCT00730561 - Hematopoietic Stem Cell Transplantation for the Treatment of Limb Ischemia and Diabetic Neuropathy N/A
Completed NCT05410548 - Comorbidity Screening and Referral by Prosthetists N/A
Enrolling by invitation NCT06229015 - Evaluation of Online Tool (E-TOOL SCS) in Spinal Cord Stimulaion
Recruiting NCT05830721 - Continuous Compartment Pressure Monitoring for Compartment Syndrome in VA-ECMO Patients N/A
Completed NCT04016857 - Remote Ischemic Preconditioning During Lower Limb Revascularization N/A
Active, not recruiting NCT04466007 - Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia Phase 2
Recruiting NCT06050499 - Chemical Analysis of Limb Microfluidics
Recruiting NCT03040063 - Complex Endovascular Approach to Treatment of Patients With Aneurysm of Popliteal Artery N/A
Completed NCT04343196 - Digital Variance Angiography in Diagnostic Angiographies for Effective Radiation Dose Reduction N/A
Not yet recruiting NCT06357936 - Nanofat Grafting as a Method of Treating Critical Limb Ischemia N/A